MICHAEL D KISHBAUCH
CIK 1076979 · CEO and President · last filed 2026-01-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
42
Lifetime Open-Market Net
-$8.86M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 6 | 2026-01-23 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 6 | 2021-06-02 |
| ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Director | 0 | — | — | -$8.86M | 17 | 2020-01-29 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | — | — | — | $0 | 7 | 2019-07-15 |
| TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Director | — | — | — | $0 | 2 | 2015-01-30 |
| ACHILLION PHARMACEUTICALS INC (TPTX) Delisted | CEO and President | — | $76.01 | — | $0 | 2 | 2008-12-17 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Director | 30,000 | — | — | $0 | 2 | 2008-01-22 |
Recent Filings · Page 2 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-05 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-25 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-14 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-07 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-13 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-28 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-15 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-19 | ACHILLION PHARMACEUTICALS INC (ACHN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-09 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-07 | Astria Therapeutics, Inc. (CATB) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.